[ad_1]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) CEO Benjamin Palleiko sold 10,940 shares of the firm’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $13.22, for a total transaction of $144,626.80. Following the completion of the transaction, the chief executive officer directly owned 386,858 shares in the company, valued at $5,114,262.76. This trade represents a 2.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
[ad_2]
Source link
KalVista Pharmaceuticals (NASDAQ:KALV) CEO Benjamin Palleiko Sells 10,940 Shares
